High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients

A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS

10.1097/00007890-199410150-00005 ◽

1994 ◽

Vol 58 (7) ◽

pp. 779-785 ◽

Cited By ~ 72

Author(s):

Maureen Martin ◽

Rafael Mañez ◽

Peter Linden ◽

David Estores ◽

Julian Torre-Cisneros ◽

...

Keyword(s):

Liver Transplant ◽

Randomized Trial ◽

Prospective Randomized Trial ◽

High Dose ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Adult Liver ◽

EFFECT OF ORAL ACYCLOVIR OR GANCICLOVIR THERAPY AFTER PREEMPTIVE INTRAVENOUS GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE ANTIBODY THERAPY1

10.1097/00007890-199812270-00036 ◽

1998 ◽

Vol 66 (12) ◽

pp. 1780-1786 ◽

Cited By ~ 37

Author(s):

Nathalie Turgeon ◽

Jay A. Fishman ◽

Nesli Basgoz ◽

Nina E. Tolkoff-Rubin ◽

Maureen Doran ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Intravenous Ganciclovir ◽

Ganciclovir Therapy ◽

Antilymphocyte Antibody ◽

A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS

10.1097/00007890-199410000-00005 ◽

1994 ◽

Vol 58 (7) ◽

pp. 779-785

Author(s):

Maureen Martin ◽

Rafael Mañez ◽

Peter Linden ◽

David Estores ◽

Julian Torre-Cisneros ◽

...

Keyword(s):

Liver Transplant ◽

Randomized Trial ◽

Prospective Randomized Trial ◽

High Dose ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Adult Liver ◽

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

Transplant International ◽

10.1111/j.1432-2277.1997.tb00725.x ◽

1997 ◽

Vol 10 (6) ◽

pp. 462-465 ◽

Cited By ~ 20

Author(s):

J. Gavaldà ◽

J. Otero ◽

A. Pahissa ◽

E. Murio ◽

C. Margarit ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

The Lancet ◽

10.1016/s0140-6736(97)05535-9 ◽

1997 ◽

Vol 350 (9093) ◽

pp. 1729-1733 ◽

Cited By ~ 370

Author(s):

Edward Gane ◽

Faouzi Saliba ◽

Garcia JC Valdecasas ◽

John O'Grady ◽

Mark D Pescovitz ◽

...

Keyword(s):

Liver Transplant ◽

Randomised Trial ◽

Oral Ganciclovir ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

The Risk Factors for Cytomegalovirus Syndrome and Tissue-invasive Cytomegalovirus Disease in Liver Transplant Recipients Who Have Cytomegalovirus Antigenemia

Transplantation Proceedings ◽

10.1016/j.transproceed.2010.02.041 ◽

2010 ◽

Vol 42 (3) ◽

pp. 890-894 ◽

Cited By ~ 6

Author(s):

J.M. Kim ◽

S.J. Kim ◽

J.-W. Joh ◽

M. Shin ◽

J.I. Moon ◽

...

Keyword(s):

Risk Factors ◽

Liver Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Surveillance Cultures of Blood, Urine, and Throat Specimens Are Not Valuable for Predicting Cytomegalovirus Disease in Liver Transplant Recipients

Clinical Infectious Diseases ◽

10.1093/clinids/24.5.824 ◽

1997 ◽

Vol 24 (5) ◽

pp. 824-829 ◽

Cited By ~ 17

Author(s):

M. E. Falagas ◽

D. R. Snydman ◽

R. Ruthazer ◽

B. G. Werner ◽

J. Griffith ◽

...

Keyword(s):

Liver Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Surveillance Cultures ◽

Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.

Antimicrobial Agents and Chemotherapy ◽

10.1128/aac.37.11.2490 ◽

1993 ◽

Vol 37 (11) ◽

pp. 2490-2492 ◽

Cited By ~ 24

Author(s):

C Lumbreras ◽

J R Otero ◽

J A Herrero ◽

R Gomez ◽

M Lizasoain ◽

...

Keyword(s):

Monoclonal Antibodies ◽

Liver Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Efficacy of Valganciclovir Administered as Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients: Impact on Viral Load and Late-Onset Cytomegalovirus Disease

10.1097/01.tp.0000146844.65273.62 ◽

2005 ◽

Vol 79 (1) ◽

pp. 85-90 ◽

Cited By ~ 93

Author(s):

Nina Singh ◽

Cheryl Wannstedt ◽

Lois Keyes ◽

Timothy Gayowski ◽

Marilyn M. Wagener ◽

...

Keyword(s):

Viral Load ◽

Liver Transplant ◽

Late Onset ◽

Preemptive Therapy ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

EFFECT OF ORAL ACYCLOVIR OR GANCYCLOVIR AFTER PREEMPTIVE INTRAVENOUS GANCYCLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE THERAPY.

10.1097/00007890-199805131-00441 ◽

1998 ◽

Vol 65 (Supplement) ◽

pp. 189

Author(s):

Nathalie Turgeon ◽

Jay A. Fishman ◽

Nesli Basgoz ◽

Nina E. Tolkoff-Rubin ◽

A. Benedict Cosimi ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽